3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
11
Other hematologic neoplasm
4
Plasma cell
3
Breast
2
Thoracic
1
Dermatologic
1
Conditions
Lung Neoplasms
24
Motor Activity
14
Carcinoma, Non-Small-Cell Lung
11
Neoplasms
3
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Gastrointestinal Neoplasms
2
Fatigue
2
Breast Neoplasms
2
Weight Loss
1
Vomiting
1
Urogenital Neoplasms
1
Stomach Neoplasms
1
Sedentary Behavior
1
Rehabilitation After Lung Cancer Surgery
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Nausea
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma
1
Lung Cancer Patients
1
Inflammation
1
Health Education
1
Esophageal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
pembrolizumab
8
Nivolumab
6
Gemcitabine
5
spartalizumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
Azacitidine
3
toripalimab
2
fludarabine
2
epacadostat
2
atezolizumab
2
Therapeutics
2
Sirolimus
2
Paclitaxel
2
Interleukin-2
2
Epoetin Alfa
2
Cisplatin
2
Bevacizumab
2
vocimagene amiretrorepvec
1
vandetanib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tislelizumab
1
temsirolimus
1
sargramostim
1
sapanisertib
1
ruxolitinib
1
rucaparib
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Exercise
×
Thoracic
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled